{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:09:47Z","timestamp":1790633387721,"version":"4.1.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>) is considered a key causative agent of gastritis, peptic ulcer, and gastric cancer, affecting more than half of the world\u2019s population. The eradication rate of antibiotic therapy gradually decreases due to the increased risk of resistance. Recent studies have shown that probiotics have good potential in the treatment of <jats:italic>H. pylori<\/jats:italic> infection. Several studies involving both human and animal models have demonstrated that probiotic interventions can inhibit <jats:italic>H. pylori<\/jats:italic> growth, attenuate H. pylori-induced gastritis, and enhance the eradication rate of antibiotics while reducing side effects. However, there remains some debate regarding the effective benefits of probiotics. The recently published reviews have not systematically elaborated on the differences in outcomes resulting from the use of probiotics of various types and doses, or the combination of probiotics with medications. They have primarily focused on animal studies, without addressing the heterogeneity of results observed in clinical research and the underlying mechanisms, thus failing to provide more high-quality evidence. This review aims to discuss the mechanisms of <jats:italic>H. pylori<\/jats:italic> infection in humans, the effects of probiotics in treating <jats:italic>H. pylori<\/jats:italic> infection, and the pathways and molecular mechanisms by which probiotics inhibit <jats:italic>H. pylori<\/jats:italic>. Future challenges include identifying effective strains, determining optimal doses and treatment durations, standardizing experimental protocols, considering individual variability, and further elucidating the specific molecular mechanisms and long-term impacts of probiotic therapy in <jats:italic>H. pylori<\/jats:italic> infection.<\/jats:p>","DOI":"10.3389\/fphar.2025.1620870","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T08:12:19Z","timestamp":1752221539000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Beyond antibiotics: probiotics as a promising ally against Helicobacter pylori"],"prefix":"10.3389","volume":"16","author":[{"given":"Lin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"135877","DOI":"10.1016\/j.foodchem.2023.135877","article-title":"Novel approach for the inhibition of Helicobacter pylori contamination in yogurt using selected probiotics combined with eugenol and cinnamaldehyde nanoemulsions","volume":"417","author":"Abdelhamid","year":"2023","journal-title":"Food Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.33696\/Pharmacol.4.045","article-title":"Recent advances in diagnosing and treating Helicobacter pylori through botanical extracts and advanced technologies","volume":"5","author":"Addissouky","year":"2023","journal-title":"Archives Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"107759","DOI":"10.1016\/j.biotechadv.2021.107759","article-title":"Synthetic biology-inspired strategies and tools for engineering of microbial natural product biosynthetic pathways","volume":"49","author":"Alam","year":"2021","journal-title":"Biotechnol. Adv."},{"key":"B4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/microorganisms12010222","article-title":"Helicobacter pylori: a contemporary perspective on pathogenesis, diagnosis and treatment strategies","volume":"12","author":"Ali","year":"2024","journal-title":"Microorganisms"},{"key":"B5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000500616","article-title":"The anti-Helicobacter pylori effects of Lactobacillus acidophilus, L. plantarum, and L. rhamnosus in stomach tissue of C57BL\/6 mice","volume":"36","author":"Asgari","year":"2020","journal-title":"Visc. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/toxins9040115","article-title":"Type IV secretion and signal transduction of Helicobacter pylori CagA through interactions with host cell receptors","volume":"9","author":"Backert","year":"2017","journal-title":"Toxins (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00203-022-03314-w","article-title":"The impacts of probiotics in eradication therapy of Helicobacter pylori","volume":"204","author":"Bai","year":"2022","journal-title":"Archives Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.26355\/eurrev_202307_33144","article-title":"The impact of probiotics on gut microbiota in the eradication of Helicobacter pylori infection: a systematic review","volume":"27","author":"Bai","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells10010027","article-title":"Helicobacter pylori virulence Factors\u2014Mechanisms of bacterial pathogenicity in the gastric microenvironment","volume":"10","author":"Baj","year":"2020","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.12998\/wjcc.v11.i20.4740","article-title":"Probiotics and autoprobiotics for treatment of Helicobacter pylori infection","volume":"11","author":"Baryshnikova","year":"2023","journal-title":"World J. Clin. Cases"},{"key":"B11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1574-6968.2000.tb08965.x","article-title":"Identification and molecular analysis of superoxide dismutase isoforms in Helicobacter pylori","volume":"183","author":"Bereswill","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3904\/kjim.2019.139","article-title":"Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy","volume":"35","author":"Chang","year":"2020","journal-title":"Korean J. Intern Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e12857","DOI":"10.1111\/hel.12857","article-title":"The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut Microbiota\u2014A double\u2010blind, placebo\u2010controlled, randomized trial","volume":"26","author":"Chen","year":"","journal-title":"Helicobacter"},{"key":"B14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/jcm8010090","article-title":"Probiotic lactobacillus spp. act against Helicobacter pylori -induced inflammation","volume":"8","author":"Chen","year":"2019","journal-title":"J. Clin. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/jcp.29925","article-title":"Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection","volume":"236","author":"Chen","year":"","journal-title":"J. Cell Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2313770","DOI":"10.1080\/19490976.2024.2313770","article-title":"Weizmannia coagulans BCF-01: a novel gastrogenic probiotic for Helicobacter pylori infection control","volume":"16","author":"Chen","year":"","journal-title":"Gut Microbes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.12998\/wjcc.v10.i19.6349","article-title":"Current guidelines for Helicobacter pylori treatment in east Asia 2022: differences among China, Japan, and South Korea","volume":"10","author":"Cho","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.3748\/wjg.v25.i18.2188","article-title":"Diversity of saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections","volume":"25","author":"Czerucka","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/medicina57070733","article-title":"Limosilactobacillus reuteri strains as adjuvants in the management of Helicobacter pylori infection","volume":"57","author":"Dargenio","year":"2021","journal-title":"Medicina"},{"key":"B21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3920\/BM2021.0151","article-title":"Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review","volume":"13","author":"Dargenio","year":"2022","journal-title":"Benef. Microbes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12602-024-10396-z","article-title":"Effects of lactobacillus spp. on Helicobacter pylori: a promising frontier in the era of antibiotic resistance","author":"Dash","year":"2024","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/antibiotics13060541","article-title":"Current and future perspectives on the management of Helicobacter pylori: a narrative review","volume":"13","author":"Deane","year":"2024","journal-title":"Antibiotics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.3748\/wjg.v25.i37.5578","article-title":"Pathogenesis and clinical management of Helicobacter pylori gastric infection","volume":"25","author":"de Brito","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1002184","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1111\/hel.12806","article-title":"Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions","volume":"26","author":"Do","year":"2021","journal-title":"Helicobacter"},{"key":"B27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s40121-020-00333-2","article-title":"Effect of Bacillus clausii capsules in reducing adverse effects associated with Helicobacter pylori eradication therapy: a randomized, double-blind, controlled trial","volume":"9","author":"Dorothea","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e12945","DOI":"10.1111\/hel.12945","article-title":"Transmission routes and patterns of Helicobacter pylori","volume":"28","author":"Duan","year":"2023","journal-title":"Helicobacter"},{"key":"B29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/antibiotics12020191","article-title":"Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges","volume":"12","author":"Elbehiry","year":"2023","journal-title":"Antibiotics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/microbiolres14030075","article-title":"Antibacterial, antibiofilm, and anti-inflammatory activities of ginger extract against Helicobacter pylori","volume":"14","author":"Elbestawy","year":"2023","journal-title":"Microbiol. Res. (Pavia)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1007\/s11033-023-08596-x","article-title":"Immunomodulatory effects of live and pasteurized Lactobacillus crispatus strain RIGLD-1 on Helicobacter pylori -triggered inflammation in gastric epithelial cells in vitro","volume":"50","author":"Fakharian","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/toxins8060173","article-title":"An overview of Helicobacter pylori VacA toxin biology","volume":"8","author":"Foegeding","year":"2016","journal-title":"Toxins"},{"key":"B33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijfoodmicro.2011.08.014","article-title":"Enterococci as probiotics and their implications in food safety","volume":"151","author":"Franz","year":"2011","journal-title":"Int. J. Food Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/microorganisms8040479","article-title":"The exopolysaccharide of Lactobacillus fermentum UCO-979C is partially involved in its immunomodulatory effect and its ability to improve the resistance against Helicobacter pylori infection","volume":"8","author":"Garcia-Castillo","year":"2020","journal-title":"Microorganisms"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3389\/fimmu.2019.02326","article-title":"Lactobacillus gasseri suppresses the production of proinflammatory cytokines in Helicobacter pylori -infected macrophages by inhibiting the expression of ADAM17","volume":"10","author":"Gebremariam","year":"2019","journal-title":"Front. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/pathogens10010015","article-title":"Rifabutin for the treatment of Helicobacter pylori infection: a review","volume":"10","author":"Gisbert","year":"2020","journal-title":"Pathogens"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2298\/VSP150415127G","article-title":"Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study","volume":"73","author":"Grgov","year":"2016","journal-title":"Vojnosanit. Pregl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00284-017-1256-4","article-title":"Role of flagella in the pathogenesis of Helicobacter pylori","volume":"74","author":"Gu","year":"2017","journal-title":"Curr. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.22088\/cjim.8.3.165","article-title":"Double strain probiotic effect on Helicobacter pylori infection treatment: a double-blinded randomized controlled trial","volume":"8","author":"Haghdoost","year":"2017","journal-title":"Casp. J. Intern Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e00202-19","DOI":"10.1128\/IAI.00202-19","article-title":"Helicobacter pylori uses the TlpB receptor to sense sites of gastric injury","volume":"87","author":"Hanyu","year":"2019","journal-title":"Infect. Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2183\/pjab.93.013","article-title":"Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer","volume":"93","author":"Hatakeyama","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e12898","DOI":"10.1111\/hel.12898","article-title":"Probiotics mitigate Helicobacter pylori \u2010induced gastric inflammation and premalignant lesions in INS\u2010GAS mice with the modulation of gastrointestinal microbiota","volume":"27","author":"He","year":"2022","journal-title":"Helicobacter"},{"key":"B43","doi-asserted-by":"publisher","first-page":"10644","DOI":"10.3748\/wjg.v21.i37.10644","article-title":"Are probiotics useful in Helicobacter pylori eradication?","volume":"21","author":"Homan","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/foods10102453","article-title":"Anti- Helicobacter pylori activity of a Lactobacillus sp. PW-7 exopolysaccharide","volume":"10","author":"Hu","year":"2021","journal-title":"Foods"},{"key":"B45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/hel.12299","article-title":"Helicobacter pylori and antibiotic resistance, a continuing and intractable problem","volume":"21","author":"Hu","year":"2016","journal-title":"Helicobacter"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1418129","DOI":"10.3389\/fmicb.2024.1418129","article-title":"Novel therapeutic regimens against Helicobacter pylori: an updated systematic review","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e12891","DOI":"10.1111\/hel.12891","article-title":"Gastric organoids: advancing the study of H. pylori pathogenesis and inflammation","volume":"27","author":"Idowu","year":"2022","journal-title":"Helicobacter"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e13017","DOI":"10.1111\/hel.13017","article-title":"Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: a randomized, double\u2010blind, placebo\u2010controlled trial","volume":"28","author":"Ismail","year":"2023","journal-title":"Helicobacter"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/ijms21031136","article-title":"Using probiotics as supplementation for Helicobacter pylori antibiotic therapy","volume":"21","author":"Ji","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/microorganisms9081611","article-title":"Effects of Lactobacillus salivarius LN12 in combination with amoxicillin and clarithromycin on Helicobacter pylori biofilm in vitro","volume":"9","author":"Jin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5009\/gnl20288","article-title":"Evidence-based guidelines for the treatment of Helicobacter pylori infection in Korea 2020","volume":"15","author":"Jung","year":"2021","journal-title":"Gut Liver"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4315\/0362-028x-66.1.3","article-title":"Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria","volume":"66","author":"Kim","year":"2003","journal-title":"J. Food Prot."},{"key":"B53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13104-020-4923-7","article-title":"Potential of selected lactic acid bacteria from Theobroma cacao fermented fruit juice and cell-free supernatants from cultures as inhibitors of Helicobacter pylori and as good probiotic","volume":"13","author":"Kouitcheu Mabeku","year":"2020","journal-title":"BMC Res. notes"},{"key":"B54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.12729\/jbtr.2020.21.3.101","article-title":"Synergistic effect of probiotic HP7 and the extracts of Perilla frutescens and Glycyrrhiza glabra to alleviate Helicobacter pylori -induced damages","volume":"21","author":"Lee","year":"2020","journal-title":"Transl. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0064521","DOI":"10.1128\/spectrum.00645-21","article-title":"Microbial diversity and composition in six different gastrointestinal sites among participants undergoing upper gastrointestinal endoscopy in Henan, China","volume":"10","author":"Li","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"17562848241258021","DOI":"10.1177\/17562848241258021","article-title":"Lactobacillus reuteri compared with placebo as an adjuvant in Helicobacter pylori eradication therapy: a meta-analysis of randomized controlled trials","volume":"17","author":"Li","year":"2024","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e13021","DOI":"10.1111\/hel.13021","article-title":"Research trends on the relationship between Helicobacter pylori and microbiota: a bibliometric analysis","volume":"28","author":"Li","year":"2023","journal-title":"Helicobacter"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1042070","DOI":"10.3389\/fcimb.2022.1042070","article-title":"Current and future perspectives for Helicobacter pylori treatment and management: from antibiotics to probiotics","volume":"12","author":"Liang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7704\/kjhugr.2022.0051","article-title":"Probiotic supplementation for treatment of Helicobacter pylori infection: a double-blind randomized clinical trial","volume":"23","author":"Lim","year":"2023","journal-title":"Korean J. Helicobacter Up. Gastrointest. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3390\/nu12082476","article-title":"Effects of multi-strain probiotics on immune responses and metabolic balance in Helicobacter pylori -infected mice","volume":"12","author":"Lin","year":"2020","journal-title":"Nutrients"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1330029","DOI":"10.3389\/fmicb.2023.1330029","article-title":"Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3748\/wjg.v24.i1.139","article-title":"Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis","volume":"24","author":"Losurdo","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Pylori infection: a 40-year journey through shifting the paradigm to transforming the management","volume":"10","author":"Malfertheiner","year":"2024","journal-title":"Dig. Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/life13071434","article-title":"Garlic extracts: effect of pH on inhibition of Helicobacter pylori","volume":"13","author":"Maria","year":"2023","journal-title":"J. Life"},{"key":"B66","doi-asserted-by":"publisher","first-page":"6612268","DOI":"10.1155\/2023\/6612268","article-title":"Helicobacter pylori exposure in nausea and vomiting of pregnancy increases risk of preterm delivery","volume":"2023","author":"Masaadeh","year":"2023","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e12529","DOI":"10.1111\/hel.12529","article-title":"Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: a randomized, double\u2010blind, placebo\u2010controlled trial","volume":"23","author":"McNicholl","year":"2018","journal-title":"Helicobacter"},{"key":"B68","doi-asserted-by":"publisher","first-page":"871","DOI":"10.31925\/farmacia.2019.5.17","article-title":"Lactobacillus reuteri\u2013An alternative in the first-line of Helicobacter pylori eradication","volume":"67","author":"Mihai","year":"2019","journal-title":"Farmacia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajg.2022.10.004","article-title":"Lactobacillus ruteri compared with placebo as an adjuvant in quadruple therapy for Helicobacter pylori eradication: a randomized, double-blind, controlled trial","volume":"24","author":"Mohtasham","year":"2023","journal-title":"Arab. J. Gastroenterol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"352","DOI":"10.15386\/mpr-1375","article-title":"Lactobacillus reuteri versus triple therapy for the eradication of Helicobacter pylori in functional dyspepsia","volume":"92","author":"Muresan","year":"2019","journal-title":"Med. Pharm. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2108655","DOI":"10.1080\/19490976.2022.2108655","article-title":"The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management","volume":"14","author":"Nabavi-Rad","year":"2022","journal-title":"Gut microbes"},{"key":"B72","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12029-023-00982-9","article-title":"The impact of traction methods on endoscopic submucosal dissection efficacy for gastric neoplasia: a systematic review and meta-analysis","volume":"55","author":"Niu","year":"","journal-title":"J. Gastrointest. Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1450414","DOI":"10.3389\/fimmu.2024.1450414","article-title":"Evaluation of efficacy and safety of Lacticaseibacillus rhamnosus LRa05 in the eradication of Helicobacter pylori: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Niu","year":"","journal-title":"Front. Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.cgh.2021.12.025","article-title":"Empirical second-line therapy in 5000 patients of the European registry on Helicobacter pylori management (Hp-EuReg)","volume":"20","author":"Nyssen","year":"","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/jcm11061658","article-title":"Experience with rifabutin-containing therapy in 500 patients from the European Registry on Helicobacter pylori management (Hp-EuReg)","volume":"11","author":"Nyssen","year":"","journal-title":"J. Clin. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fmicb.2020.00420","article-title":"Amelioration of alcohol induced gastric ulcers through the administration of Lactobacillus plantarum APSulloc 331261 isolated from green tea","volume":"11","author":"Park","year":"2020","journal-title":"Front. Microbiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00253-018-09580-3","article-title":"Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?","volume":"103","author":"Qureshi","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/microorganisms11051312","article-title":"Helicobacter pylori and its role in gastric cancer","volume":"11","author":"Reyes","year":"2023","journal-title":"Microorganisms"},{"key":"B79","first-page":"1118","article-title":"Antibacterial activity of Lactobacilli probiotics on clinical strains of Helicobacter pylori","volume":"22","author":"Rezaee","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12029-021-00630-0","article-title":"Helicobacter pylori infection mass screening for children and adolescents: a systematic review of observational studies","volume":"52","author":"Saito","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro3016","article-title":"Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori","volume":"11","author":"Salama","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/antibiotics9050244","article-title":"Antimicrobial efficacy of five probiotic strains against Helicobacter pylori","volume":"9","author":"Saracino","year":"2020","journal-title":"Antibiotics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1379209","DOI":"10.3389\/fmicb.2024.1379209","article-title":"A review for non-antibiotic treatment of Helicobacter pylori: new insight","volume":"15","author":"Shadvar","year":"2024","journal-title":"Front. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/clinchem\/hvad081","article-title":"Updates to the diagnosis and clinical management of Helicobacter pylori infections","volume":"69","author":"Shakir","year":"2023","journal-title":"Clin. Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s42770-021-00675-0","article-title":"Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms","volume":"53","author":"Sharndama","year":"2022","journal-title":"Braz J. Microbiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1196084","DOI":"10.3389\/fcimb.2023.1196084","article-title":"Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model","volume":"13","author":"Shen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e15180","DOI":"10.1097\/MD.0000000000015180","article-title":"Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine"},{"key":"B88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/CEJ.0000000000000858","article-title":"Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without saccharomyces boulardii supplementation","volume":"33","author":"Sjomina","year":"2024","journal-title":"Eur. J. Cancer Prev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/tropicalmed8030163","article-title":"Molecular mechanisms of antibiotic resistance and novel treatment strategies for Helicobacter pylori infections","volume":"8","author":"Srisuphanunt","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"72","DOI":"10.23750\/abm.v89i8-S.7947","article-title":"Helicobacter pylori, transmission routes and recurrence of infection: state of the art","volume":"89","author":"Stefano","year":"2018","journal-title":"Acta Bio Medica Atenei Parm."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1080\/19490976.2020.1762520","article-title":"The role of gastric microbiota in gastric cancer","volume":"11","author":"Stewart","year":"2020","journal-title":"Gut microbes"},{"key":"B92","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/13102818.2018.1515599","article-title":"Effects of Lactobacillus on the inhibition of Helicobacter pylori growth","volume":"32","author":"Sun","year":"2018","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"B94","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.3748\/wjg.v20.i27.8971","article-title":"Natural products and food components with anti- Helicobacter pylori activities","volume":"20","author":"Takeuchi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12866-022-02701-z","article-title":"Anti- Helicobacter pylori activity of potential probiotic Lactiplantibacillus pentosus SLC13","volume":"22","author":"Thuy","year":"2022","journal-title":"BMC Microbiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/nu14030632","article-title":"A four-probiotics regimen combined with a standard Helicobacter pylori -eradication treatment reduces side effects and increases eradication rates","volume":"14","author":"Viazis","year":"2022","journal-title":"Nutrients"},{"key":"B97","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12866-019-1517-4","article-title":"The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Microbiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"104611","DOI":"10.1016\/j.jff.2021.104611","article-title":"Lactobacillus casei T1 from kurut against Helicobacter pylori -induced inflammation and the gut microbial disorder","volume":"85","author":"Wu","year":"2021","journal-title":"J. Funct. Foods"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2300241","DOI":"10.1002\/mnfr.202300241","article-title":"Lactiplantibacillus plantarum ZJ316 reduces Helicobacter pylori adhesion and inflammation by inhibiting the expression of adhesin and urease genes","volume":"67","author":"Wu","year":"2023","journal-title":"Mol. Nutr. and food Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"10882","DOI":"10.1039\/d3fo03562j","article-title":"Anti- Helicobacter pylori activity and gastroprotective effects of human stomach-derived Lactobacillus paragasseri strain LPG-9","volume":"14","author":"Xu","year":"2023","journal-title":"Food Funct."},{"key":"B101","doi-asserted-by":"publisher","first-page":"938608","DOI":"10.3389\/fcimb.2022.938608","article-title":"Relationship between Helicobacter pylori infection and gastrointestinal microecology","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jgh.16526","article-title":"Revolution of Helicobacter pylori treatment","volume":"39","author":"Yamaoka","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e12856","DOI":"10.1111\/hel.12856","article-title":"Effects of non\u2010viable Lactobacillus reuteri combining with 14\u2010day standard triple therapy on Helicobacter pylori eradication: a randomized double\u2010blind placebo\u2010controlled trial","volume":"26","author":"Yang","year":"2021","journal-title":"Helicobacter"},{"key":"B104","doi-asserted-by":"publisher","first-page":"10069","DOI":"10.1038\/s41598-024-59399-4","article-title":"The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses","volume":"14","author":"Yang","year":"2024","journal-title":"Sci. Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12602-020-09721-z","article-title":"Effects of a potential probiotic strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori -induced inflammatory response and gene expression in coinfected gastric epithelial cells","volume":"13","author":"Yarmohammadi","year":"2021","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B106","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2352-4642(21)00400-4","article-title":"The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis","volume":"6","author":"Yuan","year":"2022","journal-title":"Lancet Child. Adolesc. Health"},{"key":"B107","doi-asserted-by":"publisher","first-page":"9985","DOI":"10.1111\/1750-3841.17514","article-title":"Weizmannia coagulans BC99 affects valeric acid production via regulating gut microbiota to ameliorate inflammation and oxidative stress responses in Helicobacter pylori mice","volume":"89","author":"Zhai","year":"2024","journal-title":"J. Food Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e12926","DOI":"10.1111\/hel.12926","article-title":"Perspectives from recent advances of Helicobacter pylori vaccines research","volume":"27","author":"Zhang","year":"2022","journal-title":"Helicobacter"},{"key":"B109","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jbiosc.2018.04.003","article-title":"Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells","volume":"126","author":"Zhao","year":"2018","journal-title":"J. Biosci. Bioeng."},{"key":"B110","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1021\/acs.jafc.1c01070","article-title":"Lactobacillus plantarum ZJ316 attenuates Helicobacter pylori -induced gastritis in C57BL\/6 mice","volume":"69","author":"Zhou","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B111","doi-asserted-by":"publisher","first-page":"e02268-16","DOI":"10.1128\/aac.02268-16","article-title":"Antimicrobial effects of antipyretics","volume":"61","author":"Zimmermann","year":"2017","journal-title":"Antimicrob. agents Chemother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"15451","DOI":"10.3390\/ijms232415451","article-title":"Lactobacilli downregulate transcription factors in Helicobacter pylori that affect motility, acid tolerance and antimicrobial peptide survival","volume":"23","author":"Zuo","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1620870\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T08:12:21Z","timestamp":1752221541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1620870\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":112,"alternative-id":["10.3389\/fphar.2025.1620870"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1620870","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"article-number":"1620870"}}